Proceedings of the National Academy of Sciences · 1995 · 120 citations · 20 references
Life SciencesInfectious DiseasesMolecular BiologyMolecular VirologyVaccinologyVirologyAntiviral AgentsAntiviral ImmunityAntiviral PharmacologyAntiviral TherapyViral InfectionsViral Rna BiologyAntiviral Drug DesignAntiviral TherapeuticsIn Vitro SelectionRibonuclease ChemistryRna Virus Biology
RNA and ribonuclease-resistant RNA analogs that bound and neutralized Rous sarcoma virus (RSV) were isolated from a large pool of random sequences by multiple cycles of in vitro selection using infectious viral particles. The selected RNA pool of RSV-binding sequences at a concentration of 0.16 microM completely neutralized the virus. Of 19 sequences cloned from the selected pool, 5 inhibited RSV infection. The selected RNA and RNA analogs were shown to neutralize RSV by interacting with the virus, rather than by adversely affecting the host cells. The selection of the anti-RSV RNA and RNA analogs by intact virions immediately suggests the potential application of this approach to develop RNA and RNA analogs as inhibitors of other viruses such as human immunodeficiency virus.
20
In vitro selection of RNA molecules that bind specific ligands
Andrew D. Ellington, Jack W. Szostak · Nature · 1990 · 9.7K citations
Kinetic Characterization of Ribonuclease-Resistant 2′-Modified Hammerhead Ribozymes
Wolfgang A. Pieken, David B. Olsen, Fritz Benseler et al. · Science · 1991 · 469 citations
Aminoacyl-RNA Synthesis Catalyzed by an RNA
Mali Illangasekare, Giselle Sánchez, Tim Nickles et al. · Science · 1995 · 346 citations